iLite® CD20 (-) Target
BM5015
iLite® ADCC Target CD20 (-) Assay Ready Cells are depleted of CD20 expression, to be used as a control for unspecific activation of ADCC that can be a confounding factor when performing ADCC assays.
iLite ADCC Target CD20 (-) Assay Ready Cells are based on a human B lymphocyte cell line, Raji (ATCC# CCL-86), and have been genetically engineered and optimized to be depleted of CD20 expression.
The cells are to be use as negative controls together with iLite® ADCC Effector (V) Assay Ready Cells and iLite® ADCC Target CD20 (+) Assay Ready Cells for measuring the ADCC activity of anti-CD20 antibodies.
FOR RESEARCH USE ONLY
At a glance
| Product code | BM5015 |
| Assay target | ADCC |
| Assay target | CD20 |
| Size | 1 vial corresponding to one 96 well plate |
| Read-out of results | Quantitative, |
| Detection system | Luminescence |
| Regulatory status | Research Use Only |
What's in the box?
>250 µL of iLite® Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010).
Documents
More content
Get access to scientific material, posters and more.